drugset / Trial / NCT00909636

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

NCT00909636

Phase 1 Completed 24 enrolled Abbott
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of escalating multiple doses of the ABT-333 tablet formulation in healthy adult subjects.

Timeline

Start
2009-05
Primary completion
2009-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator dasabuvir Small molecule 1200 mg
Comparator dasabuvir Small molecule 1600 mg